275 related articles for article (PubMed ID: 31646432)
1. Economic Burden of Anxiety Disorders: A Systematic Review and Meta-Analysis.
Konnopka A; König H
Pharmacoeconomics; 2020 Jan; 38(1):25-37. PubMed ID: 31646432
[TBL] [Abstract][Full Text] [Related]
2. The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis.
Faramarzi A; Norouzi S; Dehdarirad H; Aghlmand S; Yusefzadeh H; Javan-Noughabi J
Syst Rev; 2024 Feb; 13(1):68. PubMed ID: 38365735
[TBL] [Abstract][Full Text] [Related]
3. The excess costs of depression: a systematic review and meta-analysis.
König H; König HH; Konnopka A
Epidemiol Psychiatr Sci; 2019 Apr; 29():e30. PubMed ID: 30947759
[TBL] [Abstract][Full Text] [Related]
4. The cost of generalized anxiety disorder in primary care settings: results of the ANCORA study.
Rovira J; Albarracin G; Salvador L; Rejas J; Sánchez-Iriso E; Cabasés JM
Community Ment Health J; 2012 Jun; 48(3):372-83. PubMed ID: 22484993
[TBL] [Abstract][Full Text] [Related]
5. Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: a systematic review.
Konnopka A; Leichsenring F; Leibing E; König HH
J Affect Disord; 2009 Apr; 114(1-3):14-31. PubMed ID: 18768222
[TBL] [Abstract][Full Text] [Related]
6. Reduction in Costs after Treating Comorbid Panic Disorder with Agoraphobia and Generalized Anxiety Disorder.
Ikic V; Belanger C; Bouchard S; Gosselin P; Langlois F; Labrecque J; Dugas MJ; Marchand A
J Ment Health Policy Econ; 2017 Mar; 20(1):11-20. PubMed ID: 28418834
[TBL] [Abstract][Full Text] [Related]
7. Economic costs of antidepressant use: a population-based study in Sweden.
Beckman L; von Kobyletzki L; Svensson M
J Ment Health Policy Econ; 2019 Dec; 22(4):125-130. PubMed ID: 32058977
[TBL] [Abstract][Full Text] [Related]
8. Costs of depression in Catalonia (Spain).
Salvador-Carulla L; Bendeck M; Fernández A; Alberti C; Sabes-Figuera R; Molina C; Knapp M
J Affect Disord; 2011 Jul; 132(1-2):130-8. PubMed ID: 21402411
[TBL] [Abstract][Full Text] [Related]
9. The economic burden of mental disorders in China, 2005-2013: implications for health policy.
Xu J; Wang J; Wimo A; Qiu C
BMC Psychiatry; 2016 May; 16():137. PubMed ID: 27169936
[TBL] [Abstract][Full Text] [Related]
10. Economic burden associated with alcohol dependence in a German primary care sample: a bottom-up study.
Manthey J; Laramée P; Parrott S; Rehm J
BMC Public Health; 2016 Aug; 16(1):906. PubMed ID: 27576562
[TBL] [Abstract][Full Text] [Related]
11. The Economic Costs of Type 2 Diabetes: A Global Systematic Review.
Seuring T; Archangelidi O; Suhrcke M
Pharmacoeconomics; 2015 Aug; 33(8):811-31. PubMed ID: 25787932
[TBL] [Abstract][Full Text] [Related]
12. Human and economic burden of generalized anxiety disorder.
Hoffman DL; Dukes EM; Wittchen HU
Depress Anxiety; 2008; 25(1):72-90. PubMed ID: 17146763
[TBL] [Abstract][Full Text] [Related]
13. Cost-of-Illness in Rare Diseases.
Linertová R; García-Pérez L; Gorostiza I
Adv Exp Med Biol; 2017; 1031():283-297. PubMed ID: 29214579
[TBL] [Abstract][Full Text] [Related]
14. Cost-of-illness studies : a review of current methods.
Akobundu E; Ju J; Blatt L; Mullins CD
Pharmacoeconomics; 2006; 24(9):869-90. PubMed ID: 16942122
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.
Bereza BG; Machado M; Einarson TR
Clin Ther; 2009 Jun; 31(6):1279-308. PubMed ID: 19695395
[TBL] [Abstract][Full Text] [Related]
16. Societal burden of clinically anxious youth referred for treatment: a cost-of-illness study.
Bodden DH; Dirksen CD; Bögels SM
J Abnorm Child Psychol; 2008 May; 36(4):487-97. PubMed ID: 18214667
[TBL] [Abstract][Full Text] [Related]
17. A systematic review of the association of anxiety with health care utilization and costs in people aged 65 years and older.
Hohls JK; König HH; Raynik YI; Hajek A
J Affect Disord; 2018 May; 232():163-176. PubMed ID: 29494900
[TBL] [Abstract][Full Text] [Related]
18. Economic costs of anxiety disorders.
DuPont RL; Rice DP; Miller LS; Shiraki SS; Rowland CR; Harwood HJ
Anxiety; 1996; 2(4):167-72. PubMed ID: 9160618
[TBL] [Abstract][Full Text] [Related]
19. A clinical research practice datalink analysis of antidepressant treatment patterns and health care costs in generalized anxiety disorder.
Chollet J; Saragoussi D; Clay E; François C
Value Health; 2013 Dec; 16(8):1133-9. PubMed ID: 24326166
[TBL] [Abstract][Full Text] [Related]
20. The costs of social anxiety disorder: the role of symptom severity and comorbidities.
Stuhldreher N; Leibing E; Leichsenring F; Beutel ME; Herpertz S; Hoyer J; Konnopka A; Salzer S; Strauss B; Wiltink J; König HH
J Affect Disord; 2014 Aug; 165():87-94. PubMed ID: 24882183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
